BioPharma
Trump To Roll-Out 340B Drugs Discount Program in 2026
The Trump administration is going to pilot a voluntary program in 2026, wherein the pharmaceutical companies can offer rebates for certain drugs to hospitals that...
BioPharma
60-Day Window by Trump for Firms to Lower Their...
President Donald Trump of the USA has sent letters to the drug company CEOs demanding they lower their drug prices. The letters that have been...
BioPharma
Canada-UK Partnership Integrates Bioreactor Technologies
In a recent move, an international initiative is going to transform biologics as well as drug manufacturing by way of AI-driven multi-platform integration. The AI-optimized...
BioPharma
Bavarian Nordic Agrees for a $3 Bn Take-Private Offer
Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity firms...
BioPharma
South Korea – A Biopharma Innovation Hub With 113%...
The biopharmaceutical sector of South Korea has seen a growth in innovators and drug licensing agreements by way of reaching a total deal value of...
BioPharma
Vinay Prasad Leaves the FDA – An Abrupt End...
The head of the Food and Drug Administration office, overseeing vaccines and gene therapy, Vinay Prasad leaves the FDA after taking over his job just...
Drug Research
Resistance-Evasive Antibiotic for Genes-Free Clinics
In a startling figure, multidrug-resistant bacteria kill almost 5 million people every year, with newly resistant germs emerging faster than the scientists can actually develop the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.